Resistance Status of Aedes Aegepty Larvae Against Temephos in Gunungpati Subdistrict, Semarang
- DOI
- 10.2991/isphe-18.2018.7How to use a DOI?
- Keywords
- resistance, Aides Aegypty, temephos
- Abstract
Dengue Hemorrhagic Fever (DHF) is a major problem in Indonesia. In 2016, Incidence Rate (IR) = 77.96/100.000; Case Fatality Rate (CFR) = 0.79%. Semarang City, the Capital of Central Java Province, is an endemic area of DHF. Gunungpati is a subdistrict that has a high incidence of DHF. Some health workers sell abate (temephos) without notifying the appropriate dosage. Long-term use of larvacide and inacurate dosage may lead to resistance. This study aimed to determine the resistance status of Aedes aegypti larvae to temephos in Gunungpati sub-district. The population study was all of Ae. aegypti larvae in Gunungpati sub-district and the sample was Ae. aegypti larvae trapped by ovitrap and reared by researcher to obtain the first generation (F1). F1 larvae would be randomly exposed to temephos, with doses according to the WHO guidelines. We counted larval death after 24 hours of exposure by larval resistance indicator. This was true experiment with randomized pretest-posttest design with control group. The results showed that Ae. aegypti larvae in Gunungpati sub-district were tolerant to temephos, because the average of larvae mortality were 81-95% in temephos exposure with WHO-recommended dose.
- Copyright
- © 2018, the Authors. Published by Atlantis Press.
- Open Access
- This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Cite this article
TY - CONF AU - Widya Hari Cahyati AU - Nur Siyam PY - 2018/05 DA - 2018/05 TI - Resistance Status of Aedes Aegepty Larvae Against Temephos in Gunungpati Subdistrict, Semarang BT - Proceedings of the International Seminar on Public Health and Education 2018 (ISPHE 2018) PB - Atlantis Press SP - 29 EP - 32 SN - 2468-5739 UR - https://doi.org/10.2991/isphe-18.2018.7 DO - 10.2991/isphe-18.2018.7 ID - HariCahyati2018/05 ER -